Minimum Residual Disease in Acute Lymphoblastic Leukemia
5 vistas
• 08/04/23
0
0
Empotrar
administrator
Suscriptores
In this segment, Jeffrey Lancet, MD; Raoul Tibes, MD; and Mark R. Litzow, MD, describe various methodologies in monitoring minimum residual disease in acute lymphoblastic leukemia.
Mostrar más
Comentarios de Facebook
SORT BY-
Top Comentarios
-
Últimos comentarios